Swiss Nuclides AG
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
13.10.2025
Clinical milestones bring startups closer to launching new therapies (startupticker.ch)
10.07.2025
CHF 79 million to advance Nuclidium’s copper-based radiopharmaceutical platform (startupticker.ch)
21.10.2024
A new step in the clinical development (startupticker.ch)
27.03.2023
Nuclidium secures grant to launch phase 1 clinical trial (startupticker.ch)
29.03.2022
SERI confirms CHF 58 million SERI-funded EIC Accelerator Grants for 24 start-ups (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Swiss Nuclides AG
Website:
www.swissnuclides.ch/
Headquarter:
Aarau
Foundation Date:
June 2018
Technology:
- Biotech
Sectors:
- Biotech
- Cancer
- Diagnostics